Clinical characteristics and outcome of very elderly patients ≥90 years in intensive care: a retrospective observational study

As a result of demographic transition, the proportion of elderly and very elderly patients is increasing in industrial countries. Especially the percentage of the oldest patients (>80 years) is growing among the elderly population [1]. In 2030, the worldwide number of nonagenarians (≥90 years) is expected to reach 30 million [2].

Medical progress increasingly allows elderly patients to undergo procedures and operations that only a few decades ago were not feasible because of age [3, 4]. As a result, more very elderly patients are admitted to intensive care units (ICU). However, there is evidence that older patients have a poorer prognosis than younger patients [5–7]. Since the overall prognosis of very elderly patients is generally limited, ICU admissions in these patients are often restricted. Among intensivists and in the literature, the discussion about the appropriateness of ICU admissions of elderly patients is controversial [7–10], due to costs, limited resources, and questionable outcome.

Although international publications indicate that people 80 years of age and older already represent 15 % of all ICU patients [5, 11], there is still a lack of information on prognosis and outcome, especially the older the patient is. Only few studies on elderly patients in intensive care have included nonagenarians, who if included, only accounted for a small proportion of the study population. Especially long-term outcomes have not been studied.

This study investigated, to the best of our knowledge, the largest cohort of nonagenarians treated in the ICU and aims to analyze a large cohort of ≥90-year-old patients and their outcomes and risk factors influencing outcome.

A total of 34,392 patients were treated in the Department of Intensive Care Medicine during the study period. A total of 372 (1.1 %) patients were ≥90 years old. The median age was 92.2 years (IQR 91.0–94.2), and the proportion of female patients was 66.7 %. Before ICU admission, 230 patients (61.8 %) lived at home, 128 (34.4 %) in nursing homes, and 14 (3.7 %) at assisted living facilities.

Short-term outcomes

ICU and hospital mortality were 18.3 and 30.9 %, respectively.

Non-survivors had higher severity of disease as illustrated by SAPS II (55.8 vs. 36.1), were more likely to be male (25 vs. 14.9 %), and had more frequent unscheduled surgery or medical reasons for ICU admission (Table 1). Annual mortality rates are presented in Fig. 1.

In-patients who were admitted twice (n = 28), hospital mortality was 45.5 %. Five patients (1.3 %) were admitted three times and had a mortality rate of 80 %. 65 patients (17.5 %) had an advance directive. The decision to withhold or withdraw therapy was made in 92 patients (24.7 %). The main area of withholding therapy was pre-existing or subsequently made “Do Not Resuscitate” (73.8 %) and “Do Not Intubate” (47.8 %) orders.

In a Cox regression proportional hazard analysis in regard to 28-day survival creatinine, bilirubin, age, and necessity of catecholamine therapy were independent risk factors for worse 28-day outcome; scheduled surgery was a protective factor. Details are illustrated in Table 3a and 3b.

Variables	Hazard-ratio (95 % CI)	p value
Univariate analysis for 28-day outcome
Planned surgery	0.242 (0.143–0.409)	<0.001
Medical admission	2.156 (1.515–3.068)	<0.001
Unplanned surgery	1.357 (0.945–1.948)	0.098
Mechanical ventilation	3.186 (2.216–4.58)	<0.001
Catecholamines	2.602 (1.819–3.722)	<0.001
Renal replacement	1.379 (0.438–4.335)	0.583
Age	1.085 (1.022–1.151)	0.008
Sex (female)	0.753 (0.524–1.081)	0.124
pH	0.829 (0.626–1.097)	0.189
Leukocytes	1.032 (1.007–1.0579	0.01
Creatinine	1.328 (1.168–1.511)	<0.001
Hemoglobin	0.97 (0.872–1.079)	0.576
Bilirubin	1.435 (1.186–1.736)	<0.001
Multivariate analysis for 28-day outcome
Planned surgery	0.439 (0.225–0.856)	0.016
Medical	1.125 (0.665–1.902)	0.661
Mechanical ventilation	1.513 (0.819–2.796)	0.186
Catecholamines	2.224 (1.195–4.139)	0.012
Age	1.14 (1.045–1.243)	0.003
Leukocytes	1.017 (0.986–1.049)	0.276
Creatinine	1.224 (1.033–1.45)	0.02
Bilirubin	1.281 (1.046–1.569)	0.017

CI Confidence interval

All parameters at ICU admission

147 patients (55.1 %) were transferred to other hospitals either for further treatment or rehabilitation before moving to their final discharge destination. Details of outcomes and discharge destinations are shown in Table 4.

Results	n	%
ICU mortalitya	68	18.3
Hospital mortalitya	115	30.9
Unplanned surgery	46	38
Planned surgery	15	12.1
Medical admission	54	42.5
Withholding and/or withdrawal of therapy	93	25
Discharge destination
Home	122	47.5
Nursing care facilities	101	39.3
Short-term nursing care	17	6.6
Unknown	17	6.6
28-day mortality	149	40.1
90-day mortality	176	47.3
1-year mortality	242	65.1

^aThe latest stay was considered for calculation

ICU intensive care unit

Mid- and long-term outcomes

Long-term survival follow-up (Fig. 2) was available for 242 of 257 hospital survivors (94.2 %) and overall 357 patients. 3 months and 1 year after discharge, 196 patients (52.7 %) and 130 patients (34.9 %) of the initial study population were still alive. Surgical patients had a better one-year survival than patients admitted for medical reasons (planned surgery: 48.4 %, unplanned surgery: 33.1 % vs. 23.6 % (medical), p < 0.001).

The impact of selected factors in regard to 1 year survival is illustrated in Table 5.

Parameter	1 year survivors	1-year non-survivors	p value
Age (years), median (IQR)	92.9 (92–95.4)	91.4 (90.7–93.1)	0.101
Female (%)	75.4	61.2	0.006
Unplanned surgery (%)	30.8	33	0.659
Planned surgery (%)	46.2	26	<0.001
Medical (%)	23.1	41	0.001
Admission diagnosis
Trauma (%)	33.8	25.6	0.095
Gastrointestinal (%)	12.3	8.4	0.229
Tumor (%)	10.0	9.7	0.925
Pulmonary (%)	3.8	7.5	0.168
Neurological (%)	3.8	7.9	0.13
Cardiopulmonary resuscitation (%)	3.1	9.3	0.028
Cardiac (%)	24.6	18.1	0.14
Sepsis (%)	1.5	9.7	0.003
Others	6.9	4	0.219
Comorbidity
Arterial hypertension (%)	70.0	63.9	0.24
Cardiac diseases (%)	47.7	50.7	0.589
Chronic heart failure (%)	19.2	22.9	0.416
Cardiac arrhythmia (%)	27.7	33.9	0.223
Valvular heart disease (%)	12.3	8.4	0.229
Chronic renal insufficiency (%)	14.6	25.6	0.016
Neurodegenerative diseases (%)	21.8	78.2	0.002
Diabetes (%)	13.1	12.8	0.935
Respiratory diseases (%)	7.7	14.5	0.056
Cancer (%)	5.4	8.8	0.239
Skeletal system disorders (%)	9.2	11	0.595
Thyroid disorders (%)	16.2	7.5	0.011
Mental disorders (%)	1.5	7	0.022
Procedures on ICU
Mechanical ventilation (%)	26.2	47.6	<0.001
Catecholamines (%)	29.2	45.8	0.002
Blood transfusion (%)	14.6	24.2	0.031
Renal replacement therapy (%)	0.8	2.6	0.219
SAPS 2, median (IQR)	33 (28–44)	42 (33–53)	<0.001
pH, median (IQR)	7.35 (7.29–7.45)	7.34 (7.25–7.45)	<0.001
Bilirubin, median (IQR)	0.7 (0.5–1.1)	0.8 (0.5–1.1)	0.406
Hemoglobin, median (IQR)	9.8 (8.6–10.8)	9.6 (8.2–10.7)	0.016
Leukocytes, median (IQR)	11.9 (8.4–15.7)	11.3 (8.4–15.5)	0.048
Creatinine, median (IQR)	1.1 (0.8–1.4)	1.2 (0.9–1.8)	<0.001

This study evaluated the characteristics and outcomes of the largest cohort of nonagenarians in ICU published to date and provided data on their long-term survival.

Despite the fact that elderly patients are increasingly been treated in the intensive care environment, there is a lack of information available about their prognosis and outcome.

The 81.7 % ICU-, 70 % hospital-, and 35 % one-year survival rates stand in contrast to and challenge widespread beliefs about the poor short- and long-term prognosis of nonagenarians admitted to the ICU. Especially the hospital mortality rates of patients undergoing planned surgery were remarkably low, whereas the outcome worsened after unplanned ICU admission and especially after ICU readmission. Within the group of nonagenarians, creatinine, bilirubin, age, and necessity of catecholamine therapy cause of admission were independent factors for 28-day outcome. Not surprisingly, the 18.3 % ICU mortality of the study group of very elderly ICU patients was higher than that of the departments overall ICU mortality of 9 %. This age-related mortality risk is in line with many other outcome studies on a wide variety of critically ill ICU populations. Whereas several studies have identified age as an independent risk factor for ICU mortality [6, 7, 12–16], other studies have found the severity of illness and comorbidities to be more important risk factors than age itself [5, 17–20].

Analyzing data from a large Austrian database (n = 17,126), Ihra et al. found a significantly higher hospital mortality rate in patients older than 80 years in comparison to patients younger than 80 years (31.0 vs. 15.9 %) [5]. Only few observational studies have analyzed the outcome of the nonagenarians (≥90 years). Demoule et al. examined 36 patients ≥90 years in a French ICU. ICU and hospital mortality were 28 and 47 %, respectively [21]. Rellos et al. analyzed 60 patients ≥90 years in a Greek ICU, which accounted for 1.1 % of all ICU admissions. The average length of stay in ICU and hospital was 5 and 23 days, respectively, with an ICU mortality of 20 % [22]. Other studies with data of patients >85 years demonstrated ICU mortality rates ranging from 14.6 [6] to 36.6 % [7].

The comparability between all these studies is limited by differences in the study settings and health care systems resulting in different ICU admission policies and practices. Additionally, some studies analyzed predominantly elderly patients with unplanned ICU admissions [6], explaining differences in mortality rates between studies. In contrast, the present study included all very elderly patients treated in the ICU. One possible contributing reason for a higher mortality rate in elderly ICU patients is the fact that the decision to limit or withhold therapy occurs more frequently among elderly ICU patients. Accordingly, Seder et al. found increasing rates of withholding and withdrawal of life support in the ICU with advanced age [23], and Al-Dorzi et al. observed a more frequent application of Do Not Resuscitate- orders in patients >80 years [24]. In line with these previous findings, we recorded a quarter of very elderly ICU patients not receiving maximal therapy on the basis of an advanced directive and/or a presumed poor prognosis.

Patients admitted to the ICU following scheduled surgery had lower mortality rates than patients with unscheduled admission. Correspondingly, other studies observed the best outcome in the scheduled surgery group among very elderly patients [22, 25]. Additionally, admission for unplanned surgery was a predictor for poor outcome [25]. The differences in mortality between the three subgroups can be partly explained by the severity of acute illness. Accordingly, we observed the highest mortality rates in patients following medical admission.

At present, the average life expectancy of a 90-year-old German person is 3.8 years for men and 4.3 years for woman, and life expectancy at an age of 95 years still is 2.7 to 3 years [26]. Approximately, one-third of our entire study population was still alive at 1 year after ICU discharge. Similar findings were made by recent studies with one-year survival rates among elderly ICU patients ranging from 28 to 56 % [25, 27–30].

Limited ICU resources are one of the main reasons for controversial discussions about the accessibility of intensive care treatment for elderly patients [9]. However, findings of the recently published ELDICUS study suggest that of all patients, elderly subjects have a high benefit from ICU treatment [12].

Our study cohort represented only 1.1 % of all departmental ICU admissions from 2008 to 2013. However, the proportion of elderly patients is expected to constantly rise as a result of the demographic transition and this will also affect intensive care medicine [5, 11]. Thus, intensivists will increasingly have to cope with the special challenges of an increasingly aging ICU population and related aspects, such as multimorbidity, polypharmacy, and ethical questions. Our patients were hospitalized mainly for traumatic causes and cardiovascular diseases. Corresponding findings were made by prior studies [5–7, 11], especially the incidence of cardiovascular diseases particularly increases with advanced age [31].

The results of our study have to be interpreted with caution due to the following limitations: Because of the single-center study design, results may not be generalizable to other settings. The relatively good survival rates of our nonagenarian ICU patients may have been the result of a preselection bias of restrictions to ICU admission decisions in this age group. This important aspect was outside the scope of this study. Furthermore, our follow-up data do not provide insights into quality of life and functional status after hospital discharge. Other study groups found, that both, quality of life and autonomy in activities of daily living among elderly ICU survivors were deemed to be satisfactory [28, 32]. Further and larger multicenter studies on the long-term outcome of elderly ICU patients with regard to survival and quality of life are warranted.

Nearly 70 % of patients aged ≥90 years were discharged alive from hospital following treatment at the ICU and more than one-third were still alive 1 year after their discharge. The results suggest that long-term survival prognosis of very elderly ICU patients may be not as poor as often perceived. Chronological age per se should not be an exclusion criterion for ICU admission. Instead, the biological age, an achievable therapeutic goal and the patient’s will ought to play a major role in the decision-making process. Then, intensive care treatment may be justified even for patients with shorter life expectancy than the general population.